Bryan Eckert

Background

About Bryan Eckert

Bryan is a creative disruptor — the kind who asks uncomfortable questions, ignores bureaucratic noise, and builds what customers obsess over. He doesn’t manage decline. He reverses it. I help boards and GPs lower loss ratio, concentrate reserves behind right-tail names, and protect DPI—without diluting lead-pick precision. How: • EEve™ (Seed): scale-or-stop diligence diagnostics for Seed/Pre, using market pull, founder repeatability, and latency to first risk receipt to estimate graduation odds. • IngA Plus™ (A+): post-seed triage using receipt cadence, latency, and a public-receipts distress overlay to quantify down-round hazard and guide reserve allocation. • Board Sentinel™: escalation ≤72h, milestone-gated tranches, and “consequences before continuation” so bad news changes the plan (and spend). What this means for your fund: • Fewer write-offs → improved loss ratio and shorter time-to-write-off. • Follow-ons concentrated where fund-returner potential exists. • Less zombie drag; healthier DPI now, TVPI later. Where I plug in: • Pre-investment diligence (Seed→A) • Reserve & follow-on policy • Sales engine turnarounds • Post-acquisition recovery • Governance installs (Sentinel Seven™) Operating posture: • We publish TP/FP/TN/FN and precision/recall for Stops and Lead picks. • “Lead” is the only public winner claim; “co-lead” is a diligence track, not theater. Founder/operator with 20+ exits across Healthcare & IT. I work with boards, GPs, and family offices that value auditable decisions over decks.